OppenheimerFunds’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $585K | Sell |
4,026
-3,163
| -44% | -$460K | ﹤0.01% | 1304 |
|
|
2018
Q4 | $814K | Buy |
7,189
+2,761
| +62% | +$313K | ﹤0.01% | 1139 |
|
|
2018
Q3 | $596K | Sell |
4,428
-533
| -11% | -$71.7K | ﹤0.01% | 1365 |
|
|
2018
Q2 | $557K | Sell |
4,961
-262
| -5% | -$29.4K | ﹤0.01% | 1378 |
|
|
2018
Q1 | $558K | Buy |
5,223
+250
| +5% | +$26.7K | ﹤0.01% | 1356 |
|
|
2017
Q4 | $544K | Sell |
4,973
-152,831
| -97% | -$16.7M | ﹤0.01% | 1466 |
|
|
2017
Q3 | $17M | Buy |
157,804
+152,875
| +3,102% | +$16.5M | 0.02% | 629 |
|
|
2017
Q2 | $499K | Buy |
4,929
+216
| +5% | +$21.9K | ﹤0.01% | 1502 |
|
|
2017
Q1 | $424K | Buy |
4,713
+394
| +9% | +$35.4K | ﹤0.01% | 1561 |
|
|
2016
Q4 | $329K | Sell |
4,319
-532,540
| -99% | -$40.6M | ﹤0.01% | 1567 |
|
|
2016
Q3 | $44.7M | Buy |
536,859
+457,265
| +574% | +$38.1M | 0.06% | 356 |
|
|
2016
Q2 | $6.56M | Buy |
+79,594
| New | +$6.56M | 0.01% | 775 |
|
|
2016
Q1 | – | Sell |
-2,790
| Closed | -$224K | – | 1698 |
|
|
2015
Q4 | $224K | Buy |
+2,790
| New | +$224K | ﹤0.01% | 1621 |
|